Crossmark

Development of a clinical prognostic model for primary plasma cell leukemia patients treated with novel agents: a multicenter retrospective cohort study

Crossref DOI link: https://doi.org/10.1007/s00277-024-05862-1

Published Online: 2024-07-29

Published Print: 2024-09

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Deng, Jingjing

Qin, Xiaoqi

Ma, Guangyu

Shen, Xuliang

Sun, Jingnan

Zhao, Yanhong

Zhang, Zhihua

Sun, Ying

Jie, Guitao

Su, Liping

Ma, Jie

Tian, Weiwei

Yang, Lin

Wang, Qingming

Huang, Hongming

Shi, Mingxia

Ma, Yanping

Gao, Wen

Chen, Wenming
License Information

Text and Data Mining valid from 2024-07-29

Version of Record valid from 2024-07-29
More Information

Article History

Received: 25 March 2024

Accepted: 20 June 2024

First Online: 29 July 2024

Declarations

:

: The authors declare no conflict of interest.

Document is current

Any future updates will be listed below